MarketGrader Europe 100 Index


Five Largest Companies
Symbol Name Grade Market Cap Country
ASML.NL ASML Holding NV 60.0 ¤583,970 NL
RO.CH Roche Holding Ltd 65.1 ¤334,367 CH
AZN.GB AstraZeneca PLC 65.5 ¤314,059 GB
HSBA.GB HSBC Holdings Plc 59.3 ¤313,693 GB
NOVN.CH Novartis AG 58.7 ¤281,939 CH

Five Smallest Companies
Symbol Name Grade Market Cap Country
BOL.SE Boliden AB 55.5 ¤17,044 SE
CARL.B.DK Carlsberg AS Class B 53.2 ¤17,375 DK
STMN.CH Straumann Holding AG 53.1 ¤17,759 CH
HAL.NL HAL Trust 63.6 ¤18,557 NL
NXT.GB Next plc 68.0 ¤21,011 GB

Companies with Most Selections Among Current Components
Symbol Name Grade Times* Country
ASML.NL ASML Holding NV 60.0 34 NL
ACN Accenture Plc Class A 63.1 33 IE
DNB.NO DNB Bank ASA 56.9 30 NO
ALV.DE Allianz SE 53.6 29 DE
LR.FR Legrand SA 56.2 29 FR
NOVO.B.DK Novo Nordisk A/S Class B 61.5 29 DK
TEL TE Connectivity plc 64.5 27 IE
ETN Eaton Corp. Plc 63.9 26 IE
MUV2.DE Munchener Ruckversicherungs-Gesellschaft 47.7 26 DE
SAND.SE Sandvik AB 52.4 25 SE
*Number of times selected at Index semi-annual reconstitutions since inception date.
Index Bio
Average Market Cap ¤83,466
Median Market Cap ¤48,667
Avg. 3 Mo. Dollar Vol. ¤222,064,158
Avg. 3 Mo. Trading Vol. 4,295,057
Last Rebalance Date 03/23/2026
Companies Replaced 38
Biggest Sector Increase Industrials
Biggest Sector Decrease Health Care

Fundamental Attributes
Trailing P/E Ratio (12 Mo.) 17.8
Forward P/E Ratio (12 Mo.) 15.0
Price/Book Ratio 3.7
Avg. Revenue Chg. - 3 Yr 24.5%
Avg. Op. Income Chg. - 3 Yr. 55.3%
Avg. EPS Growth - 3 Yr. 16.3%
Avg. EPS Growth - 1 Yr. 20.3%
Avg. Operating Margin 19.9%
Avg. LT Debt to Total Capital 40.3%
Avg. Return on Equity 17.6%
Dividend Yield 2.2%
Index Average Grade
Europe 100 Index 58.68
Country Breakdown
United Kingdom 20.0%
Ireland 12.0%
Switzerland 11.0%
Germany 11.0%
Italy 8.0%
France 8.0%
Netherlands 8.0%
Sweden 8.0%
Spain 4.0%
Denmark 3.0%
Finland 2.0%
Luxembourg 2.0%
Austria 2.0%
Norway 1.0%
For more information on this index please contact us

Get Access to the World's Smartest Global Research Platform

Don't wait another day to make better informed, higher-returning investments.

TRY IT FOR FREE